| 1 |
卫小枫,李茂中,王怡婷,等. 北京地区60岁及以上老年人呼吸道合胞病毒感染流行病学和临床特征研究[J]. 中华预防医学杂志,2024, 58(7): 952-958.
|
| 2 |
成军霞,梅馨方,青刚,等. NLR与qSOFA评分对老年重症肺炎预后的临床意义[J/OL]. 中华肺部疾病杂志(电子版), 2023, 16(5): 703-705.
|
| 3 |
贾斌,梁思敏. 维生素D3对小鼠支气管哮喘气道炎症和氧化应激反应的作用及其分子机制[J]. 安徽医科大学学报,2024, 59(1): 58-63.
|
| 4 |
王蓓莹,李大鹏,张丹丹,等. 脓毒症小鼠急性肺损伤时ASAH1与细胞焦亡的关系[J]. 中华麻醉学杂志,2024, 44(7): 876-880.
|
| 5 |
中国医师协会急诊医师分会. 中国急诊重症肺炎临床实践专家共识[J]. 中国急救医学,2016, 36(2): 97-107.
|
| 6 |
韩明帅,姚佳辉,张晨. 老年脓毒症合并急性肾损伤患者肾动脉阻力指数,APACHEⅡ评分及β2微球蛋白水平与预后的关系[J]. 中国老年学杂志,2024, 44(13): 3138-3142.
|
| 7 |
Ching PR, Pedersen LL. Severe Pneumonia[J]. Med Clin North Am, 2025, 109(3): 705-720.
|
| 8 |
Martin-Loeches I, Torres A. Severe community-acquired pneumonia[J]. Semin Respir Crit Care Med, 2024, 45(2): 141-142.
|
| 9 |
熊静,唐睿,吴红梅. 重症肺炎患者肺康复治疗的研究进展[J/OL]. 中华肺部疾病杂志(电子版), 2020, 13(4): 557-559.
|
| 10 |
冯英凯,苏琛,彭波,等. 中西医结合治疗89例重症肺炎患者的疗效分析[J/OL]. 中华肺部疾病杂志(电子版), 2026, 19(2): 282-288.
|
| 11 |
Salluh JIF, Póvoa P, Beane A, et al. Challenges for a broad international implementation of the current severe community-acquired pneumonia guidelines[J]. Intensive Care Med, 2024, 50(4): 526-538.
|
| 12 |
刘燕,赵星,刘邦祺. 重庆市沙坪坝区重症肺炎患者流行病学调查[J]. 公共卫生与预防医学,2021, 32(4): 146-149.
|
| 13 |
陈丽曼,赵学影,胡威威. 老年肺炎患者诊治及其危险因素[J]. 中国老年学杂志,2025, 45(12): 3034-3037.
|
| 14 |
王鑫,姜俊. 老年性呼吸机相关性肺炎死亡危险因素分析[J]. 贵州医药,2022, 46(6): 940-941.
|
| 15 |
费志永,董宏,钱秦娟,等. 老年重症肺炎病原菌与死亡影响因素分析[J]. 中华医院感染学杂志,2019, 29(3): 380-383.
|
| 16 |
冯开俊,张泓. 血小板相关参数联合肺炎严重指数评分对重症肺炎患者病死率的预测作用[J]. 中国急救医学,2019, 39(8): 739-743.
|
| 17 |
闫红霞,马磊,颜彦,等. 重症肺炎多重耐药菌感染危险因素及NLRP3/IL-1β的预测价值[J]. 中华医院感染学杂志,2024, 34(6): 812-815.
|
| 18 |
王哲,马欣,黄芳,等. 重症肺炎患者NLRP3信号通路及相关细胞因子表达及其诊断价值[J]. 中华医院感染学杂志,2024, 34(9): 1295-1298.
|
| 19 |
Ming YL, Fei FQ, Jue W, et al. Lcn2 secreted by macrophages through NLRP3 signaling pathway induced severe pneumonia[J]. Protein & Cell, 2024, 24(45): 93.
|
| 20 |
Shi XH, Ben QW, Jun XC, et al. Enhanced activity of NLRP3 inflammasome and its proinflammatory effect in influenza a viral pneumonia[J]. Future Virology, 2023, 18(1): 21-30.
|
| 21 |
Willingham SB, Allen IC, Bergstralh DT, et al. NLRP3 (NALP3, Cryopyrin) facilitates in vivo caspase-1 activation, necrosis, and HMGB1 release via inflammasome-dependent and-independent pathways[J]. J Immunol, 2009, 183(3): 2008-2015.
|
| 22 |
He X, Mekasha S, Mavrogiorgos N, et al. Inflammation and fibrosis during Chlamydia pneumoniae infection is regulated by IL-1 and the NLRP3/ASC inflammasome[J]. J Immunol, 2010, 184(10): 5743-5754.
|
| 23 |
Yang J, Hooper WC, Phillips DJ, et al. Interleukin-1beta responses to Mycoplasma pneumoniae infection are cell-type specific[J]. Microb Pathog, 2003, 34(1): 17-25.
|
| 24 |
Li Y, Peng C, Zhao D, et al. Outer membrane protein A inhibits the degradation of caspase-1 to regulate NLRP3 inflammasome activation and exacerbate the Acinetobacter baumannii pulmonary inflammation[J]. Microb Pathog, 2021, 153(4): 104788-104788.
|
| 25 |
Tang Z, Mao Y, Ruan P, et al. Drugs targeting CMPK2 inhibit pyroptosis to alleviate severe pneumonia caused by multiple respiratory viruses[J]. J Med Virol, 2024, 96(5): 29643-29643.
|
| 26 |
王喆,马欣,黄芳,等. NLRP3、Caspase-1、IL-1β等联合检测对重症肺炎的诊断价值[J]. 中华医院感染学杂志,2024, 34(9): 1295-1298.
|
| 27 |
Chen CH, Lee YT, Shen CF, et al. Dynamic cytokine monitoring enhances CAP severity scores in elderly patients: a prospective pilot study[J]. Intern Emerg Med, 2025: 10.1007/s11739-025-03975-7.
|
| 28 |
钟明媚,徐康,丁震,等. 中性粒细胞/淋巴细胞比值与CURB-65评分在老年社区获得性肺炎预后评价中的作用[J]. 中华急诊医学杂志,2021, 30(10): 1235-1239.
|
| 29 |
杨欣,杨雪,白敏,等. CURB-65评分联合炎症因子对社区获得性肺炎住院患者预后的预测价值[J]. 中国循证医学杂志,2017, 17(6): 627-633.
|
| 30 |
葛宾,崔慧贤,梁坤,等. 外周血核苷酸结合寡聚化结构域样受体蛋白3/白细胞介素-1β、白细胞介素-18通路与重症肺炎支原体肺炎患儿预后关系及应用价值[J]. 陕西医学杂志,2024, 53(12): 1658-1662.
|
| 31 |
周红,张佩佩,刘会雪,等. 橘皮素调节TXNIP/NLRP3信号通路对重症肺炎大鼠细胞焦亡的影响[J]. 河北医学,2024, 30(8): 1279-1284.
|
| 32 |
Wang JL, Chen X, Xu YM, et al. The associations of serum IL-37 with the severity and prognosis in patients with community-acquired pneumonia: a retrospective cohort study[J]. Front Immunol, 2021, 12: 636896.
|